no statement of use filed
on 18 Sep 2023
Last Applicant/ Owned by
66 Hudson Boulevard East
New York
NY
100012192
Serial Number
88602278 filed on 03rd Sep 2019
Registration Number
N/A
Filing Basis
1. intent to use
2. intent to use current
Disclaimer
NO DATA
Pharmaceutical preparations for the treatment of autoimmune, cardiovascular, central nervous system, endocrine, gastrointestinal, genetic, immunological, infectious, inflammatory, menopausal, metabolic, musculoskeletal, neurodegenerative, neurological, neuromuscular, ophthalmological, psychiatric, respiratory, urogenital, urological and viral diseases and disorders; pharmaceutical preparations forRead More
Pharmaceutical preparations for the treatment of autoimmune, cardiovascular, central nervous system, endocrine, gastrointestinal, genetic, immunological, infectious, inflammatory, menopausal, metabolic, musculoskeletal, neurodegenerative, neurological, neuromuscular, ophthalmological, psychiatric, respiratory, urogenital, urological and viral diseases and disorders; pharmaceutical preparations for the treatment of blood disorders, liver disorders, erectile dysfunction, sexual dysfunction, cancer, pain and diabetes; pharmaceutical preparations, namely, antifungal preparations, dermatological preparations and smoking cessation preparations; vaccines for human use
No 88602278
No Service/Collective Mark
No T427890
No
No
No
No
No
No
No
No
| Status Date | Action Taken |
|---|---|
| 18th Sep 2023 | ABANDONMENT - NO USE STATEMENT FILED |
| 18th Sep 2023 | ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED |
| 28th Mar 2023 | TEAS CHANGE OF OWNER ADDRESS RECEIVED |
| 28th Mar 2023 | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED |
| 28th Mar 2023 | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED |
| 28th Mar 2023 | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
| 28th Mar 2023 | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED |
| 20th Jan 2023 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| 19th Jan 2023 | CASE ASSIGNED TO INTENT TO USE PARALEGAL |
| 19th Jan 2023 | SOU EXTENSION 5 GRANTED |
